WHO ICTRP trial
ONO-5163 Phase III long-term study (ONO-5163-04)
JPRN-jRCT2080222614 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-jRCT2080222614 |
|---|---|
| Public title | ONO-5163 Phase III long-term study (ONO-5163-04) |
| Scientific title | A Multicenter, open-label, uncontrolled, 52-week long-term study in patients with secondary hyperparathyroidism on hemodialysis (ONO-5163-04) |
| Primary sponsor | ONO PHARMACEUTICAL CO.,LTD. |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 3 |
| Countries | Japan |
| Conditions | Secondary hyperparathyroidism |
| Interventions | investigational material(s) Generic name etc : ONO-5163 INN of investigational material : Etelcalcetide Therapeutic category code : 399 Agents affecting metabolism, n.e.c. Dosage and Administration for Investigational material : Intravenous… |
| Registration date | Sep 30, 2014 |
| Target size | 180 |
| Secondary IDs | JapicCTI-142665 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: